Purpose of the company: The promotion of the founding, establishment, and further development of innovative companies in the fields of biotechnology and medicine, as well as information and communication technology and related disciplines in the Mainfranken region. The organization particularly supports cross-industry cooperation between start-ups, small and medium-sized enterprises, large industries, and applied research...
Date of articles of association: 25.7.2001
Date of first registration: 2.10.2001
Age of the company: 23,83 years
Adress: Friedrich-Bergius-Ring 15 97076 Würzburg Deutschland
Local court: 97070 Würzburg
Register number: HRB7533
The average total assets of company Betriebsgesellschaft Innovations- und Gründerzentrum Biotechnologie und -medizin / Zentrum für moderne Kommunikationstechnologien - IGZ BioMed/ZMK mbH over the last 17 years is 385.147,35 €.
The company Betriebsgesellschaft Innovations- und Gründerzentrum Biotechnologie und -medizin / Zentrum für moderne Kommunikationstechnologien - IGZ BioMed/ZMK mbH as of the reporting date 2022 a bank balance of approx. 212.339,42 €. That is 105,32 % more than the average bank balance in the industry of companies with this total assets.
The equity ratio of Betriebsgesellschaft Innovations- und Gründerzentrum Biotechnologie und -medizin / Zentrum für moderne Kommunikationstechnologien - IGZ BioMed/ZMK mbH is 22,29 % in the year 2022. In total, that ist 86.674,57 €.
The average absolute change in liquidity of the company Betriebsgesellschaft Innovations- und Gründerzentrum Biotechnologie und -medizin / Zentrum für moderne Kommunikationstechnologien - IGZ BioMed/ZMK mbH compared to the previous year amounts to 201,50 €. That means that the liquidity of the company has increased or decreased by this amount per year on average.
The cash flow of the company Betriebsgesellschaft Innovations- und Gründerzentrum Biotechnologie und -medizin / Zentrum für moderne Kommunikationstechnologien - IGZ BioMed/ZMK mbH amounts to 3.223,97 € in the year 2022.
The publication dates refer to the date on which the company published its annual financial statements in the company register. This information can provide important insights into the management of the company.
The information presented here comes from publicly accessible sources, in particular the Unternehmensregister, in which companies are obliged to disclose their annual financial statements (Sections 325 et seq. of the German Commercial Code (HGB)).
All key financial figures are based on the companies' published annual financial statements. The information is analysed automatically by Bonscore, without content processing or interpretation.
Please note that despite the utmost care, no guarantee can be given that the information provided is up-to-date, complete or correct.